MedTourChina Co-Hosts Successful CAR-T Online CME Training for Over 360 Saudi Doctors

On May 9, 2026, MedTourChina co-hosted an online CME (Continuing Medical Education) training themed "Advances in Cutting-Edge Cancer Treatment: CAR-T Innovation and Full-Cycle Clinical Management" in collaboration with Jiahui International Cancer Center (JICC), certified by the Saudi Commission for Health Specialties.

As a core co-organizer, MedTourChina played a key role in the training's planning, organization and international coordination, building an efficient communication bridge between China's top oncology teams and clinical experts in the Middle East. The training attracted over 360 oncologists and hematologists from across Saudi Arabia, with participants earning 2 official CME credits upon completion.

Led by Prof. Hao Siguo, Chief Consultant of Hematology, and Prof. Xuan Linli, Director of Medical Oncology at JICC, the training focused on CAR-T therapy principles, mechanisms, clinical applications in solid tumors and autoimmune diseases, as well as full-cycle management. It was highly praised by Saudi doctors for its clinical relevance and cutting-edge insights.

The successful event highlighted China's growing influence in medical innovation and advanced cancer treatment, while deepening cross-border medical collaboration between China and Saudi Arabia. MedTourChina stated it will continue to partner with top Chinese medical institutions to promote the global popularization of advanced oncology technologies.